Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 561

1.

Correction to: Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.

Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A; Pituitary Society, Expert Group on Pituitary Tumors.

Pituitary. 2018 Dec;21(6):663. doi: 10.1007/s11102-018-0912-4.

PMID:
30238283
2.

Abdominal Fat Graft for Sellar Reconstruction: Retrospective Outcomes Review and Technical Note.

Roca E, Penn DL, Safain MG, Burke WT, Castlen JP, Laws ER Jr.

Oper Neurosurg (Hagerstown). 2018 Aug 16. doi: 10.1093/ons/opy219. [Epub ahead of print]

PMID:
30124966
3.

Demonstration of Infectious Transgression Through the Skull Base Occurring 9 Years After Pituitary Adenoma Resection.

Liu J, Penn DL, Katznelson E, Safain MG, Dunn IF, Laws ER Jr.

World Neurosurg. 2018 Nov;119:215-219. doi: 10.1016/j.wneu.2018.08.028. Epub 2018 Aug 13.

PMID:
30114535
4.

The Role of the Lumbar Drain in Endoscopic Endonasal Skull Base Surgery: A Retrospective Analysis of 811 Cases.

Caggiano C, Penn DL, Laws ER Jr.

World Neurosurg. 2018 Sep;117:e575-e579. doi: 10.1016/j.wneu.2018.06.090. Epub 2018 Jun 20.

PMID:
29935316
5.

Advances and controversies in the classification and grading of pituitary tumors.

Laws ER Jr, Penn DL, Repetti CS.

J Endocrinol Invest. 2018 Jun 1. doi: 10.1007/s40618-018-0901-5. [Epub ahead of print] Review.

PMID:
29858984
6.

Root cause analysis of diagnostic and surgical failures in the treatment of suspected Cushing's disease.

Zaidi HA, Penn DL, Cote DJ, Laws ER Jr.

J Clin Neurosci. 2018 Jul;53:153-159. doi: 10.1016/j.jocn.2018.04.055. Epub 2018 Apr 30.

PMID:
29716804
7.

Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.

Bunevicius A, Radziunas A, Tamasauskas S, Tamasauskas A, Laws ER, Iervasi G, Bunevicius R, Deltuva V.

J Neurooncol. 2018 Jun;138(2):351-358. doi: 10.1007/s11060-018-2803-y. Epub 2018 Feb 19.

PMID:
29460097
8.

Management of non-functioning pituitary adenomas: surgery.

Penn DL, Burke WT, Laws ER.

Pituitary. 2018 Apr;21(2):145-153. doi: 10.1007/s11102-017-0854-2. Review.

PMID:
29280026
9.

Preoperative N-terminal pro-B-type natriuretic peptide concertation and prognosis of brain tumor patients: a 5-year follow up study.

Bunevicius A, Deltuva V, Laws ER, Iervasi G, Tamsauskas A, Bunevicius R.

Sci Rep. 2017 Nov 7;7(1):14775. doi: 10.1038/s41598-017-15394-6.

10.

A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery.

Burke WT, Cote DJ, Iuliano SI, Zaidi HA, Laws ER.

Pituitary. 2018 Feb;21(1):25-31. doi: 10.1007/s11102-017-0843-5.

PMID:
29075986
11.

Presentation, Treatment, and Long-Term Outcome of Intrasellar Chordoma: A Pooled Analysis of Institutional, SEER (Surveillance Epidemiology and End Results), and Published Data.

Ahmed AK, Dawood HY, Arnaout OM, Laws ER Jr, Smith TR.

World Neurosurg. 2018 Jan;109:e676-e683. doi: 10.1016/j.wneu.2017.10.054. Epub 2017 Oct 20.

PMID:
29061463
12.

Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.

Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A; Pituitary Society, Expert Group on Pituitary Tumors.

Pituitary. 2017 Oct;20(5):489-498. doi: 10.1007/s11102-017-0838-2. Erratum in: Pituitary. 2018 Sep 20;:.

13.

The extended, transnasal, transsphenoidal approach for anterior skull base meningioma: considerations in patient selection.

Castlen JP, Cote DJ, Zaidi HA, Laws ER Jr.

Pituitary. 2017 Oct;20(5):561-568. doi: 10.1007/s11102-017-0818-6.

PMID:
28689230
14.

Preoperative Stratification of Transsphenoidal Pituitary Surgery Patients Based on Surgical Urgency.

Zaidi HA, Wang AJ, Cote DJ, Smith TR, Prevedello D, Solari D, Cappabianca P, Quiroga M, Laws ER Jr.

Neurosurgery. 2017 Oct 1;81(4):659-664. doi: 10.1093/neuros/nyx073.

PMID:
28520927
15.

Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors.

Bi WL, Greenwald NF, Ramkissoon SH, Abedalthagafi M, Coy SM, Ligon KL, Mei Y, MacConaill L, Ducar M, Min L, Santagata S, Kaiser UB, Beroukhim R, Laws ER Jr, Dunn IF.

Endocrinology. 2017 Jul 1;158(7):2284-2291. doi: 10.1210/en.2016-1967.

16.

The Ethics of "Choosing Wisely": The Use of Neuroimaging for Uncomplicated Headache.

Cote DJ, Laws ER Jr.

Neurosurgery. 2017 May 1;80(5):816-819. doi: 10.1093/neuros/nyw180. Review.

PMID:
28327977
17.

Readmission and Other Adverse Events after Transsphenoidal Surgery: Prevalence, Timing, and Predictive Factors.

Cote DJ, Dasenbrock HH, Muskens IS, Broekman MLD, Zaidi HA, Dunn IF, Smith TR, Laws ER Jr.

J Am Coll Surg. 2017 May;224(5):971-979. doi: 10.1016/j.jamcollsurg.2017.02.015. Epub 2017 Mar 6.

PMID:
28279778
18.

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, Grossman A, Ikeda H, Inoshita N, Karavitaki N, Korbonits M, Laws ER Jr, Lopes MB, Maartens N, McCutcheon IE, Mete O, Nishioka H, Raverot G, Roncaroli F, Saeger W, Syro LV, Vasiljevic A, Villa C, Wierinckx A, Trouillas J; attendees of 14th Meeting of the International Pituitary Pathology Club, Annecy, France, November 2016.

Endocr Relat Cancer. 2017 Apr;24(4):C5-C8. doi: 10.1530/ERC-17-0004.

PMID:
28264912
19.

Safety of remifentanil in transsphenoidal surgery: A single-center analysis of 540 patients.

Cote DJ, Burke WT, Castlen JP, King CH, Zaidi HA, Smith TR, Laws ER, Aglio LS.

J Clin Neurosci. 2017 Apr;38:96-99. doi: 10.1016/j.jocn.2016.12.011. Epub 2017 Jan 16.

PMID:
28110927
20.

Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients.

Bunevicius A, Deltuva VP, Tamasauskas S, Smith T, Laws ER, Bunevicius R, Iervasi G, Tamasauskas A.

Oncotarget. 2017 Jan 31;8(5):8648-8656. doi: 10.18632/oncotarget.14376.

Supplemental Content

Loading ...
Support Center